Position in ABBV
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$3,032,513
+$604,021 QoQ
Shares Held
12,051
+7.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#1,643
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bangor Savings Bank holds $18,571,366 across 12 Drug Manufacturers - General names. ABBV ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
23,282 | $5,912,929 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
12,051 | $3,032,513 | |
| 3 | LLY |
ELI LILLY & Co
|
2,515 | $3,016,566 | |
| 4 | AMGN |
Amgen Inc
|
5,297 | $1,918,149 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
23,737 | $1,367,725 | |
| 6 | NVO |
Novo Nordisk A S
|
24,846 | $1,191,116 | |
| 7 | NVS |
Novartis AG
|
5,752 | $901,453 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,267 | $805,309 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,032,513 | 12,051 | Shares | Defined | 2026-07-06 | |
| 2026-03-31 | $2,428,492 | 11,166 | Shares | Defined | 2026-04-01 | |
| 2025-12-31 | $2,678,131 | 11,721 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $2,763,892 | 11,937 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $2,360,157 | 12,715 | Shares | Defined | 2025-07-07 | |
| 2025-03-31 | $2,604,123 | 12,429 | Shares | Defined | 2025-04-14 | |
| 2024-12-31 | $2,500,949 | 14,074 | Shares | Defined | 2025-01-07 | |
| 2024-09-30 | $2,771,631 | 14,035 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $2,425,978 | 14,144 | Shares | Defined | 2024-07-15 | |
| 2024-03-31 | $2,522,085 | 13,850 | Shares | Defined | 2024-04-11 | |
| 2023-12-31 | $2,200,108 | 14,197 | Shares | Defined | 2024-01-16 | |
| 2023-09-30 | $2,201,764 | 14,771 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,987,670 | 14,753 | Shares | Defined | 2023-07-07 | |
| 2023-03-31 | $2,302,417 | 14,447 | Shares | Defined | 2023-04-06 | |
| 2022-12-31 | $2,422,210 | 14,988 | Shares | Defined | 2023-01-17 | |
| 2022-09-30 | $2,519,255 | 18,771 | Shares | Defined | 2022-10-12 | |
| 2022-06-30 | $3,032,567 | 19,800 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $2,237,349 | 16,524 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,643,938 | 15,240 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,329,489 | 11,803 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $1,256,975 | 11,615 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,024,567 | 9,562 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $963,051 | 10,995 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $1,017,242 | 10,361 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $784,070 | 10,291 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||